Electronic device
    3.
    发明授权
    Electronic device 有权
    电子设备

    公开(公告)号:US09369565B2

    公开(公告)日:2016-06-14

    申请号:US14401459

    申请日:2012-07-12

    申请人: Jun Katada

    发明人: Jun Katada

    摘要: An object of the present invention is to provide an electronic device which can output audio without sound skipping and can connect to the Internet. An electronic device according to the present invention includes: communication units that communicate with an outside by predetermined communication systems including a Bluetooth (registered trademark) communication; and a communication controller that controls to communicate with the outside by any of the predetermined communication systems, wherein the communication controller secures in advance an audio-dedicated band in a frequency band used in the Bluetooth communication.

    摘要翻译: 本发明的目的是提供一种电子设备,其可以在没有声音跳过的情况下输出音频并且可以连接到因特网。 根据本发明的电子设备包括:通过包括蓝牙(注册商标)通信的预定通信系统与外部通信的通信单元; 以及控制通过任何预定通信系统与外部进行通信的通信控制器,其中通信控制器预先确保在蓝牙通信中使用的频带中的音频专用频带。

    Peptides, active as inhibitors of platelet aggregation
    5.
    发明授权
    Peptides, active as inhibitors of platelet aggregation 失效
    肽,作为血小板聚集的抑制剂有活性

    公开(公告)号:US5721213A

    公开(公告)日:1998-02-24

    申请号:US596116

    申请日:1996-01-30

    CPC分类号: A61K38/36 C07K14/745

    摘要: The present invention provides compounds and salts thereof, that are represented by the formula: Pro-Ser-A-B-Asp-C-D wherein A is an amino acid which does not contain a guanidino group as a side chain, B is a amino acid, C is a hydrophobic amino acid and D is a hydroxy group or an amino acid. The compounds of the invention have excellent platelet aggregation inhibiting and blood coagulation inhibiting activities. Also provided are reagents, pharmaceutical compositions and methods for inhibiting platelet aggregation and blood coagulation.

    摘要翻译: PCT No.PCT / JP94 / 01611 Sec。 371日期1996年1月30日 102(e)日期1996年1月30日PCT 1994年9月29日PCT公布。 出版物WO95 / 09185 日期1995年4月6日本发明提供由下式表示的化合物及其盐:Pro-Ser-AB-Asp-C-D,其中A是不含胍基作为侧链的氨基酸,B 是氨基酸,C是疏水性氨基酸,D是羟基或氨基酸。 本发明的化合物具有优异的血小板聚集抑制和抑制血液的活性。 还提供了用于抑制血小板聚集和凝血的试剂,药物组合物和方法。

    Platelet aggregation-inhibiting peptides
    6.
    发明授权
    Platelet aggregation-inhibiting peptides 失效
    血小板聚集抑制肽

    公开(公告)号:US5498601A

    公开(公告)日:1996-03-12

    申请号:US232261

    申请日:1994-05-06

    摘要: Novel peptide derivatives having RGD as a basic structure were found which have a platelet aggregation-inhibiting action, blood coagulation-inhibiting action and cell adhesion-inhibiting action.Utlizing these effects of the peptide derivatives, the following agents which comprise the peptides as active ingredients were provided: platelet aggregation-inhibiting agents that are effective in thrombolus during and after the treatment of thrombolysis and thromboembolism and that can further prevent reobstruction and cardiac infarction; blood coagulation-inhibiting agents that can inhibit blood coagulation which is the main cause of thrombus formation during extracorporeal circulation; cell adhesion-inhibiting agents; tumor metastasis-inhibiting agents; and agents for protecting platelet preparations for blood transfusion.In addition, the present invention intends to provide platelet preparation packs for blood transfusion, characterized in that the peptide dervatives are contained in platelet preparations for blood transfusion in packs.

    摘要翻译: PCT No.PCT / JP93 / 01262 Sec。 371日期:1994年5月6日 102(e)日期1994年5月6日PCT提交1993年9月7日PCT公布。 公开号WO94 / 05696 日期:1994年3月17日。发现具有RGD作为碱性结构的新型肽衍生物具有血小板聚集抑制作用,凝血抑制作用和细胞粘附抑制作用。 提供了肽衍生物的这些作用,提供了包含肽作为活性成分的以下药剂:血小板聚集抑制剂,其在治疗溶栓和血栓栓塞期间和之后都有效的血栓形成,并且可以进一步防止再梗塞和心肌梗死; 能够抑制血液凝固的血液凝固抑制剂,其是体外循环中血栓形成的主要原因; 细胞粘附抑制剂; 肿瘤转移抑制剂; 和用于保护输血血小板制剂的药剂。 此外,本发明意图提供用于输血的血小板制剂包,其特征在于肽衍生物包含在用于输液的包装的血小板制剂中。